CP-383 for squamous cell carcinoma of head and neck

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 22 Jun 2025: Trial registered, NCT07030257
  2. 27 Aug 2025: Trial started, NCT07030257

The trials

NCT07030257: Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

State
Under way
Phase
Phase 1 and Phase 2
People
150 planned
Started
27 Aug 2025
Primary completion
15 Aug 2028
Arms
Dose Level 1, Dose Level 2, Dose Level 3, Dose Level 4, Dose Level 5, Dose Level 6, Expansion Arm 1, Expansion Arm 2, Expansion Arm 3, Expansion Arm 4
Results
None posted
  1. 22 Jun 2025: Trial registered
  2. 27 Aug 2025: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.